Sally Mossman, GSK (EP.65)
Sep 21, 2020•30 min•Ep. 65
Listen to this episode in Metacast mobile app
Don't just listen to podcasts. Learn from them with transcripts, summaries, and chapters for every episode. Skim, search, and bookmark insights. Learn more
Episode description
Sally Mossman, VP, Vaccines R&D and Head Discovery Performance Unit at GSK, joins BioTalk to discuss their Rockville location, why the BioHealth Capital Region is right for the GSK, and their role in the development of a COVID-19 Vaccine.
For the best experience, listen in Metacast app for iOS or Android